Clinical Trial Update: A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial APEX is evaluating TX000045 for pulmonary hypertension secondary to heart failure with preserved ejection fraction and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• TX000045

Snippet

Sponsor: Tectonic Therapeutic | Conditions: Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: RECRUITING